RAPT Therapeutics, Inc. (RAPT)
NASDAQ: RAPT · Real-Time Price · USD
12.65
-1.29 (-9.25%)
At close: Jul 24, 2025, 4:00 PM
12.80
+0.15 (1.19%)
After-hours: Jul 24, 2025, 7:37 PM EDT
RAPT Therapeutics Analyst Ratings
Total Analysts
5
Consensus Rating
Buy
Price Target
$36.75
Upside
+190.51%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $6 → $27 | Strong Buy | Maintains | $6 → $27 | +113.44% | Jul 10, 2025 |
| UBS | UBS | Hold Maintains $16 → $8 | Hold | Maintains | $16 → $8 | -36.76% | May 22, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $48 | Strong Buy | Initiates | $48 | +279.45% | May 22, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $80 | Strong Buy | Reiterates | $80 | +532.41% | Mar 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold → Strong Buy Upgrades $80 | Hold → Strong Buy | Upgrades | $80 | +532.41% | Dec 26, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Nov 25, 2024 |
| Wells Fargo | Wells Fargo | Buy Maintains $136 → $32 | Buy | Maintains | $136 → $32 | +152.96% | Nov 12, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Nov 12, 2024 |
| JP Morgan | JP Morgan | Hold → Sell Downgrades n/a | Hold → Sell | Downgrades | n/a | n/a | Nov 11, 2024 |
| UBS | UBS | Hold Maintains $80 → $16 | Hold | Maintains | $80 → $16 | +26.48% | Sep 9, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Aug 20, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Jul 23, 2024 |
| Wolfe Research | Wolfe Research | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | May 14, 2024 |
| Barclays | Barclays | Buy → Hold Downgrades $104 → $32 | Buy → Hold | Downgrades | $104 → $32 | +152.96% | May 10, 2024 |
| Guggenheim | Guggenheim | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | May 10, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Apr 10, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.